NCT05789758 - A Study to Learn How Nusinersen (Spinraza) Affects Participants With Spinal Muscular Atrophy (SMA) Who Took it Before or During Pregnancy And About The Health of Their Babies | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 15, 2023

Primary Completion Date

October 31, 2032

Study Completion Date

October 31, 2033

Conditions

Muscular Atrophy, Spinal

Interventions

OTHER

No Intervention

Administered as specified in the treatment arm.

Trial Locations (11)

94304

RECRUITING

Stanford Neuroscience Health Center, Palo Alto

02142

ACTIVE_NOT_RECRUITING

Research Site, Cambridge

SW17 0QT

RECRUITING

St George's University NHS Foundation Trust, London

M6 8HD

RECRUITING

The Northern Care Alliance NHS Foundation Trust, Salford

SO16 6YD

RECRUITING

University Hospital Southampton NHS Foundation Trust, Southampton

NG5 1PB

RECRUITING

Nottingham University Hospitals Trust, Nottingham

SY10 7AG

RECRUITING

The Robert Jones and Agnes Hunt Orthopaedic Hospital NHS Foundation Trust, Oswestry

S10 2SB

RECRUITING

Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield

NE7 7ND

RECRUITING

The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne

B15 2GW

RECRUITING

University Hospitals Birmingham NHS Foundation Trust, Birmingham

BS10 5NB

RECRUITING

North Bristol NHS Trust, Bristol